Northwestern Medicine scientists have discovered a way to regenerate damaged heart muscle cells in mice, a development which may provide a new avenue for treating congenital heart defects in children and heart attack damage in adults, according to a study published in the Journal of Clinical Investigation.
Hypoplastic left heart syndrome, or HLHS, is a rare congenital heart defect that occurs when the left side of a baby’s heart doesn’t develop properly during pregnancy, according to the Ann & Robert H. Lurie Children’s Hospital of Chicago. The condition affects one in 5,000 newborns and is responsible for 23 percent of cardiac deaths in the first week of life.
Cardiomyocytes, the cells responsible for contracting the heart muscle, can regenerate in newborn mammals, but lose this ability with age, said Paul Schumacker, PhD, professor of Pediatrics in the Division of Neonatology and senior author of the study.
“At the time of birth, the cardiac muscle cells still can undergo mitotic cell division,” Schumacker said. “For example, if the heart of a newborn mouse is damaged when it’s a day or two old, and then you wait until the mouse is an adult, if you look at the area of the heart that was damaged previously, you’d never know that there was damage there.”
In the current study, Schumacker and his collaborators sought to understand if adult mammalian cardiomyocytes could revert to that regenerative fetal state.
Because fetal cardiomyocytes survive on glucose, instead of generating cellular energy through their mitochondria, Schumacker and his collaborators deleted the mitochondria-associated gene UQCRFS1 in the hearts of adult mice, forcing them to return to a fetal-like state.
In adult mice with damaged heart tissue, investigators observed that the heart cells began regenerating once UQCRFS1 was inhibited. The cells also began to take in more glucose, similar to how fetal heart cells function, according to the study.
The findings suggest that causing increased glucose utilization can also restore cell division and growth in adult heart cells and may provide a new direction for treating damaged heart cells, Schumacker said.
“This is a first step to being able to address one of the most important questions in cardiology: How do we get heart cells to remember how to divide again so that we can repair hearts?” said Schumacker, who is also professor of Cell and Developmental Biology and of Medicine in the Division of Pulmonary and Critical Care.
Building off this discovery, Schumacker and his collaborators will focus on identifying drugs that can trigger this response in heart cells without genetic manipulation.
“If we could find a drug that would turn on this response in the same way the gene manipulation did, we could then withdraw the drug once the heart cells have grown,” Schumacker said. “In the case of children with HLHS, this may allow us to restore the normal thickness to the left ventricular wall. That would be lifesaving.”
The approach could also be used for adults who have suffered damage due to a heart attack, Schumacker said.
“This was a big project and I’m grateful to all those involved,” Schumacker said. “There were 15 Northwestern faculty members who are co-authors on the paper, so it was really a team effort.”
The study was supported by National Institutes of Health grants HL35440, HL122062, HL118491 and HL109478.
